|
US6548490B1
(en)
|
1997-10-28 |
2003-04-15 |
Vivus, Inc. |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
GB0008694D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
|
US20030032579A1
(en)
|
2001-04-20 |
2003-02-13 |
Pfizer Inc. |
Therapeutic use of selective PDE10 inhibitors
|
|
DE10130167A1
(de)
|
2001-06-22 |
2003-01-02 |
Bayer Ag |
Imidazotriazine
|
|
WO2003014116A1
(en)
|
2001-08-06 |
2003-02-20 |
Bayer Corporation |
Pyrrolo[2.1-a]isoquinoline derivatives
|
|
US20030114469A1
(en)
*
|
2001-09-27 |
2003-06-19 |
Cohen David Saul |
Combinations
|
|
WO2004002484A1
(ja)
|
2002-06-26 |
2004-01-08 |
Kyowa Hakko Kogyo Co., Ltd. |
ホスホジエステラーゼ阻害剤
|
|
DE10230604A1
(de)
|
2002-07-08 |
2004-01-29 |
Bayer Ag |
Heterocyclisch substituierte Imidazotriazine
|
|
DE10230605A1
(de)
|
2002-07-08 |
2004-01-29 |
Bayer Ag |
Substituierte Imidazotriazine
|
|
US20070105840A1
(en)
|
2003-06-30 |
2007-05-10 |
Altana Pharma Ag |
Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
|
|
RS20050945A
(sr)
|
2003-06-30 |
2008-06-05 |
Altana Pharma Ag., |
Novi pirolodihidroizohinolini koji se mogu upotrebiti u tretmanu kancera
|
|
EP1651251A4
(en)
|
2003-07-31 |
2008-06-18 |
Bayer Pharmaceuticals Corp |
METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
|
|
EP1723134A2
(en)
|
2004-02-18 |
2006-11-22 |
Pfizer Products Incorporated |
Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
|
|
EP1755611A1
(en)
|
2004-06-07 |
2007-02-28 |
Pfizer Products Inc. |
Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
|
|
US20060019975A1
(en)
|
2004-07-23 |
2006-01-26 |
Pfizer Inc |
Novel piperidyl derivatives of quinazoline and isoquinoline
|
|
CA2578996A1
(en)
|
2004-09-03 |
2006-03-16 |
Memory Pharmaceuticals Corporation |
4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
|
|
WO2006034491A2
(en)
|
2004-09-23 |
2006-03-30 |
Bayer Pharmaceuticals Corporation |
Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
|
|
US7576080B2
(en)
|
2004-12-23 |
2009-08-18 |
Memory Pharmaceuticals Corporation |
Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
|
|
US20060183763A1
(en)
|
2004-12-31 |
2006-08-17 |
Pfizer Inc |
Novel pyrrolidyl derivatives of heteroaromatic compounds
|
|
KR100896380B1
(ko)
|
2005-01-07 |
2009-05-08 |
화이자 프로덕츠 인코포레이티드 |
헤테로방향족 퀴놀린 화합물 및 ｐｄｅ10 저해제로서의그의 용도
|
|
AU2006218054A1
(en)
|
2005-01-12 |
2006-08-31 |
Nycomed Gmbh |
Novel pyrrolodihydroisoquinolines as PDE10 inhibitors
|
|
CA2595075A1
(en)
|
2005-01-12 |
2006-07-20 |
Matthias Vennemann |
Pyrrolodihydroisoquinolines as antiproliferative agents
|
|
MX2008002207A
(es)
|
2005-08-16 |
2008-03-27 |
Memory Pharm Corp |
Inhibidores de fosfodiesterasa 10.
|
|
JP2009524637A
(ja)
|
2006-01-27 |
2009-07-02 |
ファイザー・プロダクツ・インク |
アミノフタラジン誘導体化合物
|
|
CA2643963A1
(en)
|
2006-02-21 |
2007-08-30 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
WO2007098214A1
(en)
|
2006-02-21 |
2007-08-30 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
WO2007096743A1
(en)
|
2006-02-23 |
2007-08-30 |
Pfizer Products Inc. |
Substituted quinazolines as pde10 inhibitors
|
|
US20070287707A1
(en)
|
2006-02-28 |
2007-12-13 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
|
US20090099175A1
(en)
|
2006-03-01 |
2009-04-16 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
|
US20070265258A1
(en)
|
2006-03-06 |
2007-11-15 |
Ruiping Liu |
Quinazoline derivatives as phosphodiesterase 10 inhibitors
|
|
WO2007103554A1
(en)
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
TW200817400A
(en)
|
2006-05-30 |
2008-04-16 |
Elbion Ag |
Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
|
|
TW200815436A
(en)
|
2006-05-30 |
2008-04-01 |
Elbion Ag |
4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
ES2392553T3
(es)
*
|
2006-07-10 |
2012-12-11 |
H. Lundbeck A/S |
Derivados (3-aril-piperazina-1-ilo) de 6,7-dialcoxiquinazolina, 6,7-dialcoxiftalazina y 6,7-dialcoxiisoquinolina
|
|
WO2008020302A2
(en)
|
2006-08-17 |
2008-02-21 |
Pfizer Products Inc. |
Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
|
|
CA2663178C
(en)
|
2006-09-11 |
2016-01-12 |
Matrix Laboratories Ltd. |
Dibenzofuran derivatives as inhibitors of pde-4 and pde-10
|
|
CN101166128A
(zh)
|
2006-10-16 |
2008-04-23 |
琥珀技术有限公司 |
一种提供第三方服务的方法及相应的系统
|
|
US7786139B2
(en)
|
2006-11-21 |
2010-08-31 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
EP2083819B1
(en)
|
2006-11-21 |
2017-02-22 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
US20090062277A1
(en)
|
2007-08-21 |
2009-03-05 |
Essa Hu |
Phosphodiesterase 10 inhibitors
|
|
WO2009025839A2
(en)
|
2007-08-22 |
2009-02-26 |
Amgen Inc. |
Phosphodiesterase 10 inhibitors
|
|
US20090054434A1
(en)
|
2007-08-23 |
2009-02-26 |
Amgen Inc. |
Isoquinolone derivatives as phosphodiesterase 10 inhibitors
|
|
TW200918519A
(en)
|
2007-09-19 |
2009-05-01 |
Lundbeck & Co As H |
Cyanoisoquinoline
|
|
EP2227472A1
(en)
|
2007-11-30 |
2010-09-15 |
Elbion Gmbh |
Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
|
|
US20090143361A1
(en)
|
2007-11-30 |
2009-06-04 |
Elbion Gmbh |
Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
|
|
KR20100110804A
(ko)
|
2007-11-30 |
2010-10-13 |
와이어쓰 엘엘씨 |
포스포디에스테라제 10의 저해물질로서의 아릴 및 헤테로아릴 융합된 이미다조[1,5-ａ]피라진
|
|
WO2009143178A2
(en)
|
2008-05-20 |
2009-11-26 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
US8133897B2
(en)
|
2008-06-20 |
2012-03-13 |
H. Lundbeck A/S |
Phenylimidazole derivatives as PDE10A enzyme inhibitors
|
|
TWI501965B
(zh)
|
2008-06-20 |
2015-10-01 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
|
|
JP2011526294A
(ja)
|
2008-06-25 |
2011-10-06 |
エンビボ ファーマシューティカルズ インコーポレイテッド |
ホスホジエステラーゼ１０阻害剤としての二置換フェニル化合物
|
|
BRPI0914772A2
(pt)
|
2008-06-25 |
2015-10-20 |
Envivo Pharmaceuticals Inc |
compostos heterocíclicos 1,2-dissubstituídos
|
|
EP2318410A2
(en)
|
2008-07-09 |
2011-05-11 |
Envivo Pharmaceuticals, Inc. |
New small-molecule pde-10 inhibitors
|
|
AU2009279756B2
(en)
|
2008-08-05 |
2015-01-29 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
MX2011002399A
(es)
|
2008-09-04 |
2011-04-07 |
Mitsubishi Tanabe Pharma Corp |
Compuestos pirimidina tri-sustituida y su uso como inhibidores de fosfodiesterasa 10.
|
|
CA2741303A1
(en)
|
2008-10-28 |
2010-06-03 |
Schering Corporation |
Substituted pyrazoloquinolines and derivatives thereof
|
|
WO2010054260A1
(en)
|
2008-11-07 |
2010-05-14 |
Biotie Therapies Gmbh |
Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
|
|
WO2010054253A1
(en)
|
2008-11-07 |
2010-05-14 |
Biotie Therapies Gmbh |
Triazine derivatives as inhibitors of phosphodiesterases
|
|
TW201030001A
(en)
|
2008-11-14 |
2010-08-16 |
Amgen Inc |
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
|
|
SG171954A1
(en)
|
2008-12-04 |
2011-07-28 |
Hoffmann La Roche |
Pyridazinone derivatives
|
|
ES2397934T3
(es)
|
2008-12-17 |
2013-03-12 |
Amgen Inc. |
Compuestos de aminopiridina y carboxipiridina como inhibidores de fosfodiesterasa 10
|
|
AU2010211050B2
(en)
|
2009-02-05 |
2016-05-12 |
Takeda Pharmaceutical Company Limited |
Pyridazinone compounds
|
|
US9187455B2
(en)
|
2009-02-23 |
2015-11-17 |
Hoffmann-La Roche Inc. |
Substituted pyridazines as PDE10A inhibitors
|
|
EP2400991A1
(en)
|
2009-02-24 |
2012-01-04 |
Janssen Pharmaceutica, N.V. |
Radiolabelled pde10 ligands
|
|
US8685967B2
(en)
|
2009-04-07 |
2014-04-01 |
Merck Sharp & Dohme Corp. |
Substituted triazolopyridines and analogs thereof
|
|
CN105125547A
(zh)
|
2009-05-07 |
2015-12-09 |
费瑞姆医药有限公司 |
苯氧基甲基杂环化合物
|
|
EP2434885B1
(en)
|
2009-05-27 |
2014-03-26 |
Merck Sharp & Dohme Corp. |
Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
|
|
AU2010254149B2
(en)
|
2009-05-29 |
2014-08-21 |
Merck Sharp & Dohme Llc |
Radiolabeled PDE10 inhibitors
|
|
WO2010138585A1
(en)
|
2009-05-29 |
2010-12-02 |
Merck Sharp & Dohme Corp. |
Pyrimidinones as pde10 inhibitors
|
|
TW201111383A
(en)
|
2009-05-29 |
2011-04-01 |
Wyeth Llc |
Substituted imidazo[1,5-a]quinoxalines as inhibitors of phosphodiesterase 10
|
|
CA2765750A1
(en)
|
2009-06-19 |
2010-12-23 |
H. Lundbeck A/S |
Novel phenylimidazole derivative as pde10a enzyme inhibitor
|
|
EP2467382B1
(en)
|
2009-08-17 |
2014-06-25 |
Merck Sharp & Dohme Corp. |
Amino tetrahydro-pyridopyrimidine pde10 inhibitors
|
|
PE20121438A1
(es)
|
2009-09-24 |
2012-10-26 |
Hoffmann La Roche |
Derivados de imidazopiridina o imidazopirimidina como inhibidores de fosfodiesterasa 10a
|
|
WO2011053559A1
(en)
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Aryl aminopyridine pde10 inhibitors
|
|
KR101774035B1
(ko)
|
2009-10-30 |
2017-09-01 |
얀센 파마슈티카 엔.브이. |
이미다조［１，２―ｂ］피리다진 유도체 및 ＰＤＥ１０ 저해제로서의 그의 용도
|
|
AU2010311493B2
(en)
|
2009-10-30 |
2014-06-05 |
Janssen Pharmaceutica Nv |
Radiolabelled PDE10 ligands
|
|
TWI485151B
(zh)
|
2009-12-17 |
2015-05-21 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
|
|
TWI481607B
(zh)
|
2009-12-17 |
2015-04-21 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物
|
|
TWI487705B
(zh)
|
2009-12-17 |
2015-06-11 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物
|
|
TW201200516A
(en)
|
2009-12-17 |
2012-01-01 |
Lundbeck & Co As H |
Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors
|
|
US8470820B2
(en)
|
2010-01-22 |
2013-06-25 |
Hoffman-La Roche Inc. |
Nitrogen-containing heteroaryl derivatives
|
|
ES2540867T3
(es)
|
2010-02-26 |
2015-07-14 |
Mitsubishi Tanabe Pharma Corporation |
Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
|
|
JP2011201873A
(ja)
|
2010-03-03 |
2011-10-13 |
Mitsubishi Tanabe Pharma Corp |
三置換ピリミジン化合物及びそのｐｄｅ１０阻害薬としての使用
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
KR101713453B1
(ko)
|
2010-03-12 |
2017-03-07 |
오메로스 코포레이션 |
Pde10 억제제 및 관련 조성물 및 방법
|
|
US8410117B2
(en)
|
2010-03-26 |
2013-04-02 |
Hoffmann-La Roche Inc. |
Imidazopyrimidine derivatives
|
|
WO2011132048A1
(en)
|
2010-04-19 |
2011-10-27 |
Glenmark Pharmaceutical S.A. |
Heteroaryl compounds as pde10a inhibitors
|
|
WO2011132051A2
(en)
|
2010-04-19 |
2011-10-27 |
Glenmark Pharmaceuticals S.A. |
Tricycle compounds as phosphodiesterase-10 inhibitors
|
|
WO2011138657A1
(en)
|
2010-05-04 |
2011-11-10 |
Glenmark Pharmaceuticals S.A. |
Aryl substituted olefinic compounds as pde10a inhibitors
|
|
JP2013526546A
(ja)
|
2010-05-13 |
2013-06-24 |
アムジエン・インコーポレーテツド |
Ｐｄｅ１０阻害剤としてのヘテロアリ−ルオキシヘテロシクリル化合物
|
|
AU2011253058A1
(en)
|
2010-05-13 |
2012-12-06 |
Amgen Inc. |
Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
|
|
WO2011143365A1
(en)
|
2010-05-13 |
2011-11-17 |
Amgen Inc. |
Nitrogen heterocyclic compounds useful as pde10 inhibitors
|
|
US8969349B2
(en)
|
2010-05-26 |
2015-03-03 |
Sunovion Pharmaceuticals Inc. |
Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
|
|
US8703768B2
(en)
|
2010-06-09 |
2014-04-22 |
Hoffmann-La Roche Inc. |
Nitrogen containing heteroaryl compounds
|
|
WO2011163355A1
(en)
|
2010-06-24 |
2011-12-29 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
|
|
TW201215607A
(en)
|
2010-07-02 |
2012-04-16 |
Lundbeck & Co As H |
Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor
|
|
TW201206935A
(en)
|
2010-07-16 |
2012-02-16 |
Lundbeck & Co As H |
Triazolo-and pyrazoloquinazoline derivatives as PDE10A enzyme inhibitor
|
|
CA2827724A1
(en)
|
2011-02-18 |
2012-08-23 |
Allergan, Inc. |
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
|
|
US9200016B2
(en)
*
|
2013-12-05 |
2015-12-01 |
Allergan, Inc. |
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
|